Polar Asset Management Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Polar Asset Management Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35,000	Closed	-$4.05M	–	1036
2023 Q3	$4.05M	Sell	35,000 -410,000	-92%	-$44.1M	0.09%	268
2023 Q2	$45.8M	Buy	445,000 +215,000	+93%	+$22.7M	0.82%	14
2023 Q1	$25.1M	Buy	230,000 +55,000	+31%	+$6.08M	0.38%	44
2022 Q4	$19.9M	Buy	+175,000	New	+$14.5M	0.24%	88

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Polar Asset Management Partners's HZNP Position: Q4 2023 in Review

Polar Asset Management Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 35,000 shares — an estimated $4.05M sold.

Polar Asset Management Partners first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $45.8M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Polar Asset Management Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Polar Asset Management Partners sold 35,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.05M.
Polar Asset Management Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
Polar Asset Management Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $45.8M in Q2 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.